Takeda to soon start trials in India for dengue vaccine

Takeda Pharmaceuticals' dengue vaccine assumes significance since the first vaccine ever licensed for dengue, developed by French drugmaker Sanofi Pasteur, met with failure as it only helped people who had been previously infected with the virus.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news